Hofmann V
Schweiz Med Wochenschr. 1982 Nov 27;112(48):1718-23.
In the majority of monoclonal gammopathies it is not possible to demonstrate an association with an underlying disease related to multiple myeloma, Waldenström's macroglobulinemia, malignant lymphoma or amyloidosis. After a lapse of months to years, however, some patients will develop one of the diseases mentioned. Since no test can identify patients at risk, periodic controls of the M-component are necessary.
在大多数单克隆丙种球蛋白病中,无法证明其与多发性骨髓瘤、华氏巨球蛋白血症、恶性淋巴瘤或淀粉样变性等潜在疾病有关。然而,数月至数年之后,部分患者会患上上述某种疾病。由于尚无检测方法能够识别有风险的患者,因此有必要定期监测M蛋白成分。